A new chance for EGFR inhibition in glioblastoma?

Neuro Oncol. 2019 Dec 17;21(12):1487-1488. doi: 10.1093/neuonc/noz196.
No abstract available

Publication types

  • Comment

MeSH terms

  • Brain Neoplasms*
  • ErbB Receptors
  • Glioblastoma*
  • Humans
  • Temozolomide

Substances

  • EGFR protein, human
  • ErbB Receptors
  • Temozolomide